Market reporting

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

Voting at the ballot box
#India #Life sciences #Market reporting #Politics #UK government #United States

The politics of health: How 2024 elections will impact life sciences

With elections this year in the US, the UK and India – all major players in the life sciences industry – Ivor Campbell, Chief Executive, Snedden Campbell, asks what changes and benefits we can expect to see for companies and their investors, healthcare providers and patients. The global landscape for… Read More

#Exclusive Content #Trends & Analysis

#Advanced Therapies #Advanced Therapy Medicinal Products (ATMPs) #CAR-T #Cell and gene therapy #Cell therapy #Gene therapy #Guide #Market reporting

Podcast: The global innovation and the opportunity in CGTs

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The promise and growth of cell and gene therapies… Read More

#News

#Biotech #Biotech hubs #Drug discovery hotspots #Market reporting

Where are the global hotspots for biotech?

The future is looking rosy for the biotechnology sector. Diana Spencer takes a world-tour of some of the key centres of innovation.  According to data analysts Precedence Research, the global biotechnology market was estimated at $1.38 trillion in 2023 and is expected to be worth around $4.25 trillion by 2033,… Read More

#Business & Investment #Exclusive Content #Market Reports

Neuroscience concept
#Drug discovery #In Focus Report #Market reporting #Neuroscience

New eReport: Advances in neuroscience research

The global prevalence of dementia is approximately 24 million, and is predicted to double every 20 years until at least 2040. Currently, no medications can cure this, though 2024 has proved to be a poignant year of developments in neuroscience, especially considering the challenges faced in previous decades. This guide… Read More

#News

Drug Discovery World report on Neuroscience
#Drug discovery #In Focus Report #Market reporting #Neuroscience

Neuroscience: Advances in research and opportunities ahead

Download this In Focus eReport to learn more about the drug discovery innovation and advancement taking place in this field. The eReport includes: A global market overview including prevalence, value and future outlook A scientific article on developing therapeutics targeting biomolecular condensates An interview with ApconiX’s Director and Co-founder, Professor… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

#Biopharma #Biopharmaceuticals #GlobalData #Market reporting

Biopharma industry optimistic about growth in the next year

The biopharmaceutical industry is revealing increasing optimism regarding its growth prospects over the next 12 months. While the upward trend is a positive sign, it remains below the levels of confidence seen in 2022, finds data and analytics company GlobalData. In a recent survey, ‘The State of the Biopharmaceutical Industry 2024… Read More

#Business & Investment #News

#Diabetes #GlobalData #Market reporting #Weight loss

GLP-1 receptor agonists market to reach $125 billion by 2033

Glucagon-like peptide-1 (GLP-1) receptor agonist sales for the type 2 diabetes and obesity markets are forecast to reach over $125 billion in the seven major markets (7MM) by 2033, according to analysts GlobalData. GLP-1 receptor agonists like Ozempic (semaglutide) are a class of incretin mimetic medicines for the treatment of… Read More

#News #Trending News #Trends & Analysis

The European Medicines Agency in Amsterdam
#Drug discovery #Europe #France #Lithuania #Market reporting #Netherlands #Switzerland

Europe: Where is the drug discovery innovation?

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW's Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in… Read More

#Exclusive Content #Market Reports

#Cancer research #In Focus Report #Market reporting #Oncology

DDW In Focus eReport: Oncology breakthroughs and innovation

Created by DDW and sponsored by HUB Organoids, ‘Oncology research: Where are the breakthroughs and innovation?’  is a free In Focus report now available to download. Oncology represents the drug discovery and development sector’s biggest focus area and whilst novel treatments continue to emerge… Read More

#News

#Antimicrobial resistance (AMR) #Cell and gene therapy #Europe #Immunology / Virology & Vaccines #Market reporting #mRNA #Plant-based

Read the Spring issue of DDW now

The Spring issue of Drug Discovery World (DDW) is out now. It looks at where we are in the fight against antimicrobial resistance, explores how structural biology is informing vaccine design, and offers advice on approaching dealmaking in biopharma. Read the digital version here. … Read More

#News

Singapore skyline
#Asia #Biotech hubs #Market reporting #Singapore

Can Singapore become a global hub for biotech?

With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences? DDW’s Diana Spencer explores how the country is turning pioneering science into a successful biotech industry. Thanks to significant investment by the government into research and development, Singapore has… Read More

#Exclusive Content #Market Reports

#ADME / Tox #Cellular assays #Drug toxicity #Market reporting #Omics #Toxicology

Late-stage drug failures drive toxicology testing market growth

The global ADME toxicology testing market is predicted to generate a revenue of $19.21 billion by 2030, with a growth rate of 10.2%. Factors such as an increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid… Read More

#Business & Investment #News

Stock market
#Diabetes #Eli Lilly #GlobalData #Market reporting #Novo Nordisk #Vertex #Weight loss

Lilly, Novo Nordisk and Vertex lead on market capitalisation growth

The top 20 global biopharmaceutical companies have reported 1.6% market capitalisation growth to $3.67 trillion in 2023, according to data analysts GlobalData. The top 20 global biopharmaceutical companies experienced varied year-on-year (YoY) market capitalisation shifts in 2023 amid the macroeconomic headwinds, steep patent cliffs and the commencement of US drug… Read More

#Business & Investment #News

Someone using a keyboard
#AI / data analytics / healthtech / informatics #Data management #Informatics #Market reporting

Drug discovery informatics market predicted to grow 12.6% by 2028

The drug discovery informatics market is predicted to grow from $3.77 billion in 2024 to $6.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%, according to analysts ResearchAndMarkets.com. The recent growth in the market is attributed to advancements in genomics and proteomics, the escalating complexity of… Read More

#Business & Investment #Market Reports #News #Trends & Analysis